There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
5637.03 Cr.Face value
1.00Book value
25.22Div. yield
0.000P/E ratio
0.00P/B ratio
8.48Debt/Eq.
-Market Cap
5637.03 Cr.Face value
1.00Book value
25.22Div. yield
0.00%P/E ratio
0.00P/B ratio
8.48Debt/Eq.
-
| Mar 26 | Dec 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 70.15% | 67.36% | 2.79% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists. Suven offer research 
It discovers and develops novel clinical-stage therapeutics targeting neurodegenerative disorders and CNS diseases with a comprehensive multi-asset pipeline including several late-stage candidates.
Incorporated in 1989, the company is based in Hyderabad, Telangana, operating two research centers in Telangana.
Suven has 1 subsidiary based in the USA, focusing on clinical development of new chemical entity molecules.
